PUBLIC COMPANY
save$LSTALISATA THERAPEUTICS, INC.
$LSTABasking Ridge, NJ, USupdated 2mo ago
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
- phase2A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
- phase2Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
- phase1CLBS119 for Repair of COVID-19 Induced Pulmonary Damage
- phase1CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
- phase2Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
- phase1CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
- phase1Vaccine Therapy in Treating Patients With Kidney Cancer
🐶 Hiring Signal
News
- After one failed acquisition attempt, Lisata finds lifeline in Marea mergerAfter a failed merger that led to massive layoffs and a lawsuit, solid tumor biotech Lisata Therapeutics has found a new future through a merger with cardio specialist Marea Therapeutics.fiercebiotech · 14d ago
Data sources
last refreshed 57m ago
Found something off?
comments(0)
5-min edit window · permanent after that